1. Home
  2. SCPH vs PROP Comparison

SCPH vs PROP Comparison

Compare SCPH & PROP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • PROP
  • Stock Information
  • Founded
  • SCPH 2013
  • PROP 2001
  • Country
  • SCPH United States
  • PROP United States
  • Employees
  • SCPH N/A
  • PROP N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • PROP Investment Bankers/Brokers/Service
  • Sector
  • SCPH Health Care
  • PROP Finance
  • Exchange
  • SCPH Nasdaq
  • PROP Nasdaq
  • Market Cap
  • SCPH 173.6M
  • PROP 190.0M
  • IPO Year
  • SCPH 2017
  • PROP N/A
  • Fundamental
  • Price
  • SCPH $2.57
  • PROP $4.10
  • Analyst Decision
  • SCPH Strong Buy
  • PROP
  • Analyst Count
  • SCPH 3
  • PROP 0
  • Target Price
  • SCPH $14.00
  • PROP N/A
  • AVG Volume (30 Days)
  • SCPH 519.0K
  • PROP 832.2K
  • Earning Date
  • SCPH 05-13-2025
  • PROP 01-01-0001
  • Dividend Yield
  • SCPH N/A
  • PROP N/A
  • EPS Growth
  • SCPH N/A
  • PROP N/A
  • EPS
  • SCPH N/A
  • PROP N/A
  • Revenue
  • SCPH $36,332,000.00
  • PROP $7,939,000.00
  • Revenue This Year
  • SCPH $114.00
  • PROP $8,816.87
  • Revenue Next Year
  • SCPH $77.45
  • PROP N/A
  • P/E Ratio
  • SCPH N/A
  • PROP N/A
  • Revenue Growth
  • SCPH 167.28
  • PROP N/A
  • 52 Week Low
  • SCPH $1.94
  • PROP $3.35
  • 52 Week High
  • SCPH $5.65
  • PROP $16.08
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 47.35
  • PROP 36.89
  • Support Level
  • SCPH $1.94
  • PROP $3.92
  • Resistance Level
  • SCPH $2.71
  • PROP $4.49
  • Average True Range (ATR)
  • SCPH 0.27
  • PROP 0.50
  • MACD
  • SCPH 0.04
  • PROP 0.04
  • Stochastic Oscillator
  • SCPH 76.36
  • PROP 31.99

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

About PROP Prairie Operating Co.

Prairie Operating Co is a Houston-based independent energy company engaged in the development and acquisition of oil and natural gas resources in the United States. The Company's assets and operations are concentrated in the oil and liquids-rich regions of the Denver-Julesburg (DJ) Basin, with a focus on the Niobrara and Codell formations. The Company is committed to the responsible development of its oil and natural gas resources and is focused on maximizing returns through consistent growth, capital discipline, and sustainable cash flow generation.

Share on Social Networks: